Bacterin International Holdings

Biologics
Our products are engineered to provide superior handling characteristics for the surgeon.  Our OsteoSponge^® allograft is compressible, our OsteoWrap^® is flexible, and our OsteoSelect^® DBM Putty features a consistency that allows it to stay in place even in wet surgical environments.  To learn more about other products and competitive advantages please click on the individual product pages.

While we too could stop at aseptic processing and rely on tissue decontamination processes to ensure safety, we take safety to the next level by providing a sterility assurance level of 10-6 via low-dose gamma irradiation.  Research over the past 20 years has shown that low-dose gamma irradiation provides an additional means of allograft safety while not significantly compromising the natural integrity or biologic performance of the allograft.  Presently, we test DBM processed from every donor for osteoinductive potential in an animal model AFTER low-dose gamma irradiation.

OsteoSponge^®

OsteoSponge^® was created by Bacterin with the patient and the physician in mind. The product consists of 100% human cancellous bone that has been demineralized to provide a value-added benefit over other allografts. The demineralization process assists with two functions: 1) it makes the product compressible so it is ideal for surgeons to obtain a press-fit, precise placement of the graft; and 2) it exposes the native growth factors and bone morphogenic proteins that are essential to induce new bone formation. OsteoSponge^® also maintains the natural interconnected porosity of cancellous bone providing an ideal scaffold for cellular infiltration and bone formation.

Elutia^® Wound Drains

Patient safety is important; that is why Bacterin created the first antimicrobial–coated wound drain. Elutia^® channel drains feature a micron-thin hydrogel coating that is intended to inhibit microbial contamination of the drain. Contained within the coating is silver sulfadiazine, an antimicrobial agent known for pronounced efficacy against microorganisms.

Elutia^® wound drains are available in multiple sizes, and in round or flat styles. They are available with and without a pre-attached trocar and evacuation reservoirs are also available (sold separately). Uncoated drains are also available with and without a pre-attached trocar as Bacterin’s family of Via™ wound drains.

For more information CLICK HERE

Guy Cook, Chairman, CEO, President and Chief Scientific Officer

Expert in biofilm science and its application. Product specialist in the Image Analysis Department for Laboratory Equipment Company in Chicago; President of Delta Resources in Crystal Lake, Illinois(specialized in developing customized image analysis solutions for the academic community); Confocal Microscopist for the Center for Biofilm Engineering at the Montana State University (developed proprietary med device testing models).

Mitchell T. Godfrey, Director

25 years consulting and participation in firms in the manufacturing, medical devices, nuclear, service and animal health industries; Lieutenant in the U.S. Navy for a period of four years in the 1960s; Director of the Utah Vietnam Agent Orange Program; Chairman of the Montana based Crow Creek Falls Conservation Group.

Michael Lopach, Director and Audit Committee Chairman

Served 27 years with Galusha, Higgens, Galusha & Co., the largest privately held accounting firm in Montana and northern Idaho, a firm established in 1919 that employs 60 accounting professionals in six offices, where he served as president and CEO. In 1999, founded Lopach & Carparelli PC, an accounting firm that focuses on medical practitioners. Certified public account; University of Notre Dame MBA.

Kent Swanson, Director and Compensation Committee Chairman

Senior Partner of Accenture (retired after 32 years); Board Chair of ALN Medical Management; Board Chair for Boys Hope Girls Hope of Colorado; Board member, Audit Committee member and Compensation Committee Chair for MPC Computers(2002 to 2009); University of Chicago MBA (1969).

Jon M. Wickwire, Director and Chairman of Corporate Governance and Nominating Committees

Attorney and founding shareholder of Wickwire Gavin, P.C., a national construction law firm, which merged with Akerman Senterfitt, one of the top 100 law firms in the U.S. Served as lead counsel on major infrastructure litigation and alternative dispute resolutions throughout his 30 year career. Graduate of the University of Maryland and Georgetown University Law Center.